Bayer Faced with $2.1 Billion Jury Verdict Over Roundup Cancer Claims in Georgia

Atlanta, Georgia — A jury in Georgia has recently mandated Bayer, a German chemical conglomerate, to pay a staggering $2.1 billion in damages to a plaintiff who claimed that the company’s widely used weedkiller, Roundup, was responsible for his cancer. This substantial verdict is one of the highest in the series of lawsuits related to Roundup. Bayer, which has contested the verdict, affirmed on March 22 its plans to appeal. The company argues that the judgment contradicts a plethora of scientific evidence supporting the safety of glyphosate, Roundup’s primary ingredient, validated by global regulatory bodies. … Read more

Georgia Jury Hits Bayer-Monsanto with Staggering $2.1 Billion Ruling in Cancer Lawsuit

Atlanta, GA — A staggering $2.1 billion verdict has been handed down by a Georgia jury against agrochemical giants Bayer and Monsanto, marking another significant ruling in the litany of legal challenges surrounding the controversial weedkiller, Roundup. In a recent decision, the jury ordered the companies to pay compensatory and punitive damages for causing non-Hodgkin’s lymphoma in a plaintiff, intensifying the scrutiny on the safety of widely used herbicides. This landmark case underlines the ongoing debate over the safety of glyphosate, the active ingredient in Roundup, which is classified as a probable human carcinogen by … Read more

Georgia Jury Orders Monsanto to Pay $2 Billion in Landmark Roundup Cancer Case

MARIETTA, Ga. — A significant legal ruling emerged from Cobb County State Court as a jury awarded a multi-billion dollar judgment against agrochemical giant Monsanto, now owned by Bayer, concerning its widely-used Roundup weed killer. The decision marks one of the largest punitive damages awards in recent history, reflecting growing legal challenges the company faces over its product. Plaintiff John Barnes, a 55-year-old who developed non-Hodgkin lymphoma after prolonged exposure to Roundup, received $65 million in compensatory damages for his illness. Diagnosed in 2020, Barnes had used the herbicide extensively over a period of 20 … Read more

Johnson & Johnson Subsidiary Fined $1.64 Billion Over Misleading HIV Drug Promotions

Philadelphia, PA – A U.S. jury has ruled against a Johnson & Johnson subsidiary, ordering the pharmaceutical giant to pay $1.64 billion in a landmark case that accuses the company of misleading marketing practices related to its HIV treatments. This verdict marks one of the largest in a series of legal challenges faced by the company. The case revolved around the allegations that Janssen Pharmaceuticals, a unit of Johnson & Johnson, engaged in false and misleading promotion of its drugs used to treat HIV. The lawsuit claimed that the company failed to adequately warn patients … Read more